Rs41291957 polymorphism in the promoter region of microRNA‑143 serves as a prognostic biomarker for patients with intracranial hemorrhage

Yang,Xiaobo; Guo,Zongduo; Cao,Fang; Teng,Zhipeng; Huang,Zhijian; Sun,Xiaochuan

doi:10.3892/mmr.2021.11928

Rs41291957 polymorphism in the promoter region of microRNA‑143 serves as a prognostic biomarker for patients with intracranial hemorrhage

Authors:
- Xiaobo Yang
- Zongduo Guo
- Fang Cao
- Zhipeng Teng
- Zhijian Huang
- Xiaochuan Sun
View Affiliations

Affiliations: Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China, Department of Cerebrovascular Disease, The First Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, P.R. China, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400000, P.R. China
Published online on: February 23, 2021 https://doi.org/10.3892/mmr.2021.11928
Article Number: 295
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the function of the single nucleotide polymorphism (SNP) rs41291957 in the prognosis of intracerebral hemorrhage (ICH). In addition, the molecular mechanisms underlying the role of microRNA (miR)‑143, Toll‑like receptor 2 (TLR2) and interleukin‑16 (IL‑16) were studied in patients with ICH that carried different alleles in the locus of the rs41291957 SNP. Kaplan‑Meier survival curves were calculated for 182 patients with ICH, genotyped as CC, presenting a cytosine in both chromosome, CT, presenting both variants, and TT, presents a thymine in both chromosomes. In addition, the possible regulatory relationships between miR‑143 and TLR2/IL‑16 were studied using computational analysis, luciferase assays and western blot assay. In addition, the inflammatory profiles of cerebrospinal fluid (CSF) and serum samples collected from the subjects were compared. The patients genotyped as TT presented the lowest survival rate, while patients genotyped as CC presented the highest survival rate. TLR2 mRNA was identified as a potential target of miR‑143, while IL‑16 showed no direct interaction with miR‑143. The above regulatory relationships were further investigated using cells transfected with miR‑143 precursor or TLR2 small interfering RNA. In addition, the expression levels of inflammatory factors, such as tumor necrosis factor α, interferon, IL‑6, IL‑10 and NF‑L‑6, were highest in the CSF/serum samples collected from patients genotyped as TT and lowest in patients genotyped as CC. By contrast, the expression levels of miR‑143 showed an opposite trend in the expression of the above inflammatory factors. The rs41291957 SNP, located in the promoter region of miR‑143, reduced the expression of miR‑143 and upregulated the expression of the pro‑inflammatory factor TLR2, eventually leading to a poorer prognosis in patients with ICH.

View Figures

View References

1	Wang MD, Wang Y, Xia YP, Dai JW, Gao L, Wang SQ, Wang HJ, Mao L, Li M, Yu SM, et al: High serum miR-130a levels are associated with severe perihematomal edema and predict adverse outcome in acute ICH. Mol Neurobiol. 53:1310–1321. 2016. View Article : Google Scholar : PubMed/NCBI
2	Rincon F, Friedman DP, Bell R, Mayer SA and Bray PF: Targeted temperature management after intracerebral hemorrhage (TTM-ICH): Methodology of a prospective randomized clinical trial. Int J Stroke. 9:646–651. 2014. View Article : Google Scholar : PubMed/NCBI
3	Zhang Y, Chen Y, Wu J, Manaenko A, Yang P, Tang J, Fu W and Zhang JH: Activation of dopamine D2 receptor suppresses neuroinflammation through αB-crystalline by inhibition of NF-κB nuclear translocation in experimental ICH mice model. Stroke. 46:2637–2646. 2015. View Article : Google Scholar : PubMed/NCBI
4	Xu C, Wang T, Cheng S and Liu Y: Increased expression of T cell immunoglobulin and mucin domain 3 aggravates brain inflammation via regulation of the function of microglia/macrophages after intracerebral hemorrhage in mice. J Neuroinflammation. 10:1412013. View Article : Google Scholar : PubMed/NCBI
5	Chen M, Li X, Zhang X, He X, Lai L, Liu Y, Zhu G, Li W, Li H, Fang Q, et al: The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: Contribution of TSG-6. J Neuroinflammation. 12:612015. View Article : Google Scholar : PubMed/NCBI
6	Lei B, Dawson HN, Roulhac-Wilson B, Wang H, Laskowitz DT and James ML: Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation. 10:1032013. View Article : Google Scholar : PubMed/NCBI
7	Harder LM, Bunkenborg J and Andersen JS: Inducing autophagy: A comparative phosphoproteomic study of the cellular response to ammonia and rapamycin. Autophagy. 10:339–355. 2014. View Article : Google Scholar : PubMed/NCBI
8	Wakisaka Y, Chu Y, Miller JD, Rosenberg GA and Heistad DD: Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. J Cereb Blood Flow Metab. 30:56–69. 2010. View Article : Google Scholar : PubMed/NCBI
9	Rincon F and Mayer SA: Novel therapies for intracerebral hemorrhage. Curr Opin Crit Care. 10:94–100. 2004. View Article : Google Scholar : PubMed/NCBI
10	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
11	Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, Ramnath N, Gotoh N, Beer DG and Chen G: A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 5:124642015. View Article : Google Scholar : PubMed/NCBI
12	Akao Y, Nakagawa Y and Naoe T: MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep. 16:845–850. 2006.PubMed/NCBI
13	Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, et al: Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med. 16:49–58. 2010. View Article : Google Scholar : PubMed/NCBI
14	Xie H, Lim B and Lodish HF: MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 58:1050–1057. 2009. View Article : Google Scholar : PubMed/NCBI
15	Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 460:705–710. 2009. View Article : Google Scholar : PubMed/NCBI
16	Li L, Pan X, Li Z, Bai P, Jin H, Wang T, Song C, Zhang L and Gao L: Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum Immunol. 74:993–997. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wu D, Huang P, Wang L, Zhou Y, Pan H and Qu P: MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. Mol Med Rep. 8:626–630. 2013. View Article : Google Scholar : PubMed/NCBI
18	Yin X, Sun S, Zhao J, Yang J, Lei X, Xu C and Li K: Rs4705342 polymorphism is involved in the tumorigenesis of HBV positive HCC by altering the binding affinity of HBV induced NF-κB with the promoter region of microRNA-143. J Cell Biochem. 119:5233–5242. 2018. View Article : Google Scholar : PubMed/NCBI
19	Liu X, Gong J and Xu B: miR-143 down-regulates TLR2 expression in hepatoma cells and inhibits hepatoma cell proliferation and invasion. Int J Clin Exp Pathol. 8:12738–12747. 2015.PubMed/NCBI
20	Min H, Hong J, Cho IH, Jang YH, Lee H, Kim D, Yu SW, Lee S and Lee SJ: TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models. Mol Brain. 8:232015. View Article : Google Scholar : PubMed/NCBI
21	Wang YC, Zhou Y, Fang H, Lin S, Wang PF, Xiong RP, Chen J, Xiong XY, Lv FL, Liang QL and Yang QW: Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol. 75:876–889. 2014. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Burns JD, Fisher JL and Cervantes-Arslanian AM: Recent advances in the acute management of intracerebral hemorrhage. Neurosurg Clin N Am. 29:263–272. 2018. View Article : Google Scholar : PubMed/NCBI
24	Bernales S, Schuck S and Walter P: ER-phagy: Selective autophagy of the endoplasmic reticulum. Autophagy. 3:285–287. 2007. View Article : Google Scholar : PubMed/NCBI
25	Bampton ET, Goemans CG, Niranjan D, Mizushima N and Tolkovsky AM: The dynamics of autophagy visualized in live cells: From autophagosome formation to fusion with endo/lysosomes. Autophagy. 1:23–36. 2005. View Article : Google Scholar : PubMed/NCBI
26	Bai Y, Zhang Y, Han B, Yang L, Chen X, Huang R, Wu F, Chao J, Liu P, Hu G, et al: Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. J Neurosci. 38:32–50. 2018. View Article : Google Scholar : PubMed/NCBI
27	Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A and Abraham E: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 279:7370–7377. 2004. View Article : Google Scholar : PubMed/NCBI
28	Huang QQ, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM II, Tak PP, Haines GK III, Nicchitta CV and Pope RM: Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol. 182:4965–4973. 2009. View Article : Google Scholar : PubMed/NCBI
29	Ohashi K, Burkart V, Flohé S and Kolb H: Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 164:558–561. 2000. View Article : Google Scholar : PubMed/NCBI
30	Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD and Wagner H: HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem. 277:15107–15112. 2002. View Article : Google Scholar : PubMed/NCBI
31	Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C and Simon JC: Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 195:99–111. 2002. View Article : Google Scholar : PubMed/NCBI
32	Bsibsi M, Bajramovic JJ, Van Duijvenvoorden E, Persoon C, Ravid R, Van Noort JM and Vogt MH: Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins. Glia. 55:473–482. 2007. View Article : Google Scholar : PubMed/NCBI
33	Hanke ML and Kielian T: Toll-like receptors in health and disease in the brain: Mechanisms and therapeutic potential. Clin Sci (Lond). 121:367–387. 2011. View Article : Google Scholar : PubMed/NCBI
34	Lehnardt S: Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 58:253–263. 2010.PubMed/NCBI
35	Weiss SJ: Tissue destruction by neutrophils. N Engl J Med. 320:365–376. 1989. View Article : Google Scholar : PubMed/NCBI
36	Albers DS and Beal MF: Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl. 59:133–154. 2000.PubMed/NCBI
37	Franklin JL: Redox regulation of the intrinsic pathway in neuronal apoptosis. Antioxid Redox Signal. 14:1437–1448. 2011. View Article : Google Scholar : PubMed/NCBI
38	Valencia A and Morán J: Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radic Biol Med. 36:1112–1125. 2004. View Article : Google Scholar : PubMed/NCBI
39	Guo H, Chen Y, Hu X, Qian G, Ge S and Zhang J: The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells. Mol Cancer. 12:772013. View Article : Google Scholar : PubMed/NCBI
40	Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang Y, Ye S, Wu S, Zhong G, Ren J, et al: MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci. 9:680–692. 2013. View Article : Google Scholar : PubMed/NCBI
41	Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G, Liu Q and Du J: MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene. 517:197–204. 2013. View Article : Google Scholar : PubMed/NCBI
42	Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer. 11:232012. View Article : Google Scholar : PubMed/NCBI
43	Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG and Burns CE: The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development. 137:1887–1896. 2010. View Article : Google Scholar : PubMed/NCBI
44	Miyasaka KY, Kida YS, Banjo T, Ueki Y, Nagayama K, Matsumoto T, Sato M and Ogura T: Heartbeat regulates cardiogenesis by suppressing retinoic acid signaling via expression of miR-143. Mech Dev. 128:18–28. 2011. View Article : Google Scholar : PubMed/NCBI